3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
6
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Multiple Myeloma
2
Lymphoma, Follicular
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Spinocerebellar Degenerations
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Recurrence
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Malignant Solid Neoplasm
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatic Insufficiency
1
Gallbladder Neoplasms
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
5
Cisplatin
4
enfortumab vedotin
2
Ramucirumab
2
Platinum
2
Docetaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
vinflunine
1
rucaparib
1
pembrolizumab
1
eribulin
1
enzalutamide
1
dehydroftorafur
1
carotuximab
1
avelumab
1
atezolizumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Interleukin-7
1
Immunoglobulin G
1
Icrucumab
1
IMC-18F1
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ureteral Neoplasms
×
copanlisib
×
Clear all
No trials found.